Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MAVACAMTEN vs MECHLORETHAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MAVACAMTEN vs MECHLORETHAMINE: Safety Overview

Metric MAVACAMTEN MECHLORETHAMINE
Total FAERS Reports 3,250 2,579
Deaths Reported 79 266
Death Rate 2.4% 10.3%
Hospitalizations 454 291
Average Patient Age 66.6 yrs 63.7 yrs
% Female Patients 69.1% 47.0%
FDA Approval Date Apr 28, 2022 Approved Prior to Jan 1, 1982
Manufacturer Myokardia, Inc. Helsinn Therapeutics (U.S.), Inc.
Route ORAL TOPICAL
Marketing Status Prescription Discontinued